Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
This week, Novo Nordisks Wegovy pill gets FDA approval
When combined with semaglutide, which also lowers blood glucose, there is theoretical potential for additive glucose-lowering effects, particularly in patients with diabetes who should monitor blood glucose levels more frequently
These findings indicate that Nano-GTE supplementation at 100 g/mL effectively protected sperm cells against cryo-induced structural damage and improved post-thaw performance, whereas excessive concentrations had adverse effects on motility and morphology
Explore our comprehensive catalog of individual research peptides, custom blends, and synthesis services